456 related articles for article (PubMed ID: 25249308)
1. Challenges and opportunities for next-generation sequencing in companion diagnostics.
Lin E; Chien J; Ong FS; Fan JB
Expert Rev Mol Diagn; 2015 Feb; 15(2):193-209. PubMed ID: 25249308
[TBL] [Abstract][Full Text] [Related]
2. Targeted next-generation sequencing panels for monogenetic disorders in clinical diagnostics: the opportunities and challenges.
de Koning TJ; Jongbloed JD; Sikkema-Raddatz B; Sinke RJ
Expert Rev Mol Diagn; 2015 Jan; 15(1):61-70. PubMed ID: 25367078
[TBL] [Abstract][Full Text] [Related]
3. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
4. Next-generation sequencing in precision oncology: challenges and opportunities.
Kruglyak KM; Lin E; Ong FS
Expert Rev Mol Diagn; 2014 Jul; 14(6):635-7. PubMed ID: 24791810
[TBL] [Abstract][Full Text] [Related]
5. Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan.
Shimazawa R; Ikeda M
Expert Rev Mol Diagn; 2020 Jun; 20(6):601-610. PubMed ID: 32064968
[TBL] [Abstract][Full Text] [Related]
6. Next-generation sequencing and its applications in molecular diagnostics.
Su Z; Ning B; Fang H; Hong H; Perkins R; Tong W; Shi L
Expert Rev Mol Diagn; 2011 Apr; 11(3):333-43. PubMed ID: 21463242
[TBL] [Abstract][Full Text] [Related]
7. The first FDA marketing authorizations of next-generation sequencing technology and tests: challenges, solutions and impact for future assays.
Bijwaard K; Dickey JS; Kelm K; Težak Ž
Expert Rev Mol Diagn; 2015 Jan; 15(1):33-40. PubMed ID: 25370936
[TBL] [Abstract][Full Text] [Related]
8. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
[TBL] [Abstract][Full Text] [Related]
9. Companion diagnostics: the key to personalized medicine. Foreword.
Jørgensen JT
Expert Rev Mol Diagn; 2015 Feb; 15(2):153-6. PubMed ID: 25597758
[TBL] [Abstract][Full Text] [Related]
10. [The application of next generation sequencing on epigenetic study].
Shen S; Qu Y; Zhang J
Yi Chuan; 2014 Mar; 36(3):256-75. PubMed ID: 24846966
[TBL] [Abstract][Full Text] [Related]
11. Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy.
Hagemann IS; Cottrell CE; Lockwood CM
Cancer Genet; 2013 Dec; 206(12):420-31. PubMed ID: 24388712
[TBL] [Abstract][Full Text] [Related]
12. Translating exome sequencing from research to clinical diagnostics.
Coonrod EM; Margraf RL; Voelkerding KV
Clin Chem Lab Med; 2011 Dec; 50(7):1161-8. PubMed ID: 22850020
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology.
Cronin M; Ross JS
Biomark Med; 2011 Jun; 5(3):293-305. PubMed ID: 21657839
[TBL] [Abstract][Full Text] [Related]
14. Next-generation sequencing, cancer and molecular diagnostics: an interview with Elaine Mardis.
Mardis E; Raison C
Expert Rev Mol Diagn; 2015 Apr; 15(4):449-50. PubMed ID: 25795041
[TBL] [Abstract][Full Text] [Related]
15. Molecular testing in oncology: problems, pitfalls and progress.
O'Brien CP; Taylor SE; O'Leary JJ; Finn SP
Lung Cancer; 2014 Mar; 83(3):309-15. PubMed ID: 24472389
[TBL] [Abstract][Full Text] [Related]
16. Perspective for the development of companion diagnostics and regulatory landscape to encourage personalized medicine in Japan.
Tazawa Y
Breast Cancer; 2016 Jan; 23(1):19-23. PubMed ID: 25605056
[TBL] [Abstract][Full Text] [Related]
17. Next-generation sequencing in the clinic: promises and challenges.
Xuan J; Yu Y; Qing T; Guo L; Shi L
Cancer Lett; 2013 Nov; 340(2):284-95. PubMed ID: 23174106
[TBL] [Abstract][Full Text] [Related]
18. Impact of next generation sequencing on diagnostics in a genetic skin disease clinic.
Takeichi T; Nanda A; Liu L; Salam A; Campbell P; Fong K; Akiyama M; Ozoemena L; Stone KL; Al-Ajmi H; Simpson MA; McGrath JA
Exp Dermatol; 2013 Dec; 22(12):825-31. PubMed ID: 24279917
[TBL] [Abstract][Full Text] [Related]
19. Integrating next-generation sequencing into the diagnostic testing of inherited cancer predisposition.
Ku CS; Cooper DN; Iacopetta B; Roukos DH
Clin Genet; 2013 Jan; 83(1):2-6. PubMed ID: 23020236
[TBL] [Abstract][Full Text] [Related]
20. Next-generation sequencing for lung cancer.
Wu K; Huang RS; House L; Cho WC
Future Oncol; 2013 Sep; 9(9):1323-36. PubMed ID: 23980680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
